Safety First Trust Series 2009-2 (ABI)

0.23 1.01
Prev Close 22.75
Open 22.98
Day Low/High 22.98 / 22.98
52 Wk Low/High 18.94 / 24.20
Volume 630.00
Exchange n.a.
Shares Outstanding 2.36M
Market Cap 54.32M
Div & Yield N.A. (N.A)

Friday's Health Winners & Losers

Regulatory setbacks helped push Medicines Co. and other biotech stocks down.

Applied Biosystems Sees Loss

The fiscal first quarter saw a one-time $114.3 million charge. Ratings: Two Funds for Your Fiscal Health

A contrarian strategy gives you exposure to the renewed interest in health care-related stocks.

Tuesday's Health Winners & Losers

SkyePharma falls, but Vasogen is higher.

Recession-Proof Your Portfolio

Consider these themes when looking to help boost a portfolio's resistance to recession.

Applera, Beckman Coulter Settle Patent Dispute

They agree to royalty-bearing licenses.

Tuesday's Health Winners & Losers

CollaGenex jumps 11% after the FDA approves its pill to treat rosacea.

Applied Bio Buying Agencourt

Beckman Coulter expects to get $50 million in cash.

Solexa Builds a Better Gene Trap

Its efficient genome-sequencing technology will put the company on the map.

Health Stocks in Motion

NeoPharm soars.

Health Stocks in Motion

Hologics rallies on earnings.

Health Stocks in Motion

Vivus is climbing after positive results from a study.

Affymetrix on the Ascent

The stock is up 68% over the past year, and more gains could be in store as the company's technology grows.

Health Stocks in Motion

Lifeway Foods up on deal with Target.

Portfolios Could Use a Dose of Biotech

The sector epitomizes high risk/high reward, but adding some biotech to your portfolio is wise.

Health Stocks in Motion

Medco falls 8% despite hitting targets.

Corporate Cash Kings

Firms are setting more money aside for a rainy day. See which ones top the list.

The Kings of Corporate Cash

Companies are setting more money aside for a rainy day. See which ones top the list.

$10 and $20 Stocks That Can Make You 20%

You don't need a lot of money to turn a profit that would make Warren Buffett proud.

General Electric in Biotech Deal

The conglomerate teams up with Celera Genomics and Applied Biosystems to fight cancer.

Vigilance and Volume in Taking Trades

Here's some clarification on volume confirmation. Plus, FirstEnergy, Kraft and more.

Equipment Makers Have Cause to Fear Pharma Consolidation

Some of the projected savings from big deals such as Pfizer-Pharmacia may come from equipment orders.

Waters' Warning Runs Downhill, Soaking Biotech Equipment Makers

The news has analysts rethinking rosy assumptions about the short-term health of this group.

Affymetrix Tumbles Amid a Glut of Downgrades After Monday's Warning

Analysts are concerned with a lack of visibility, but most see a bright spot in the firm's dominant position.

Biotech's Wonder Twins Outline Their Growing Pains

Celera and Applied Biosystems met or beat estimates, but the future looks fuzzy.

Molecular Devices Finds Biotech Slowdown Is Contagious

Molecular Devices become the second equipment maker to report lower-than-expected earnings.

Applied Biosystems at the Bottom of the Big Board's Steepest Slide

Sky-high valuation and a revenue warning make it the NYSE's worst quarterly performer.

Sometimes You Get the Bear, Sometimes the Bear Gets You

The chip sector may have moved higher today, but the bears are still out there.